AboutTermsPrivacyContact
 
Updating
Society of Interventional Oncology Podcast

Society of Interventional Oncology Podcast

Released: 2025-10-08
© 2025
Society of Interventional Oncology Podcast - QR Code
4 Episodes
Audio
Listen on Apple Podcasts
4 Episodes
Audio
Listen on Apple Podcasts
Released: 2025-10-08
© 2025
Most Recent Episode
Episode 4: Ablation vs. Ablation + Combination Immune Therapy

Episode 4: Ablation vs. Ablation + Combination Immune Therapy

Meet the Data: Conversations with Leading Experts on the Role of HCC and Immunotherapy SIO Meet the Data Series: Explore the evolving landscape of hepatocellular carcinoma treatment in this four-part podcast series, featuring conversations with leading
Time: 1:09:39
Meet the Data: Conversations with Leading Experts on the Role of HCC and Immunotherapy
SIO Meet the Data Series: Explore the evolving landscape of hepatocellular carcinoma treatment in this four-part podcast series, featuring conversations with leading experts on the role of immunotherapy. This series features expert discussions highlighting emerging clinical trial evidence and addressing key knowledge gaps relevant to the implementation of these novel therapeutic regimens into clinical practice.
Episode 4: Ablation vs. Ablation + Combination Immune Therapy
Can combining ablation with immune therapy improve patient outcomes in liver cancer? Experts Gentry King and Isabel Newton examine the latest clinical data comparing ablation alone versus ablation plus immune therapy. Moderated by Elena Violari, the discussion evaluates efficacy, recurrence rates, and synergistic mechanisms, while exploring how cancer stage, tumor location, and genetic markers guide patient selection for these evolving treatment strategies.
Moderator:
•    Elena Violari, MD | Loyola University Chicago
Faculty:
•    Gentry King, MD | University of Washington
•    Isabel G. Newton, MD, PhD | University of California San Diego
Resources
Gentry King, MD
https://www.fredhutch.org/en/provider-directory/gentry-king.html
Isabel G. Newton, MD, PhD
https://providers.ucsd.edu/details/22369/radiology
Checkmate 90W Trial:
https://ascopubs.org/doi/full/10.1200/JCO.22.01436
IMbrave150 Trial
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2824%2900800-6/fulltext
LEAP-012 Trial:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)02575-3/abstract
Emerald-Y90 Trial:
https://ascopubs.org/doi/10.1200/JCO.2025.43.16_suppl.TPS4221
Disclaimer
This discussion is intended for healthcare professionals for educational purposes only. It does not constitute medical advice and should not replace individualized patient care decisions.
Episode ID: 1000733707310
GUID: 6b899325-01a4-4447-b4b4-58c575b7bc02
Release Date: 08/10/2025, 01:45:00

Description

Meet the Data: Conversations with Leading Experts on the Role of HCC and Immunotherapy SIO Meet the Data Series: Explore the evolving landscape of hepatocellular carcinoma treatment in this four-part podcast series, featuring conversations with leading experts on the role of immunotherapy. This series features expert discussions highlighting emerging clinical trial evidence and addressing key knowledge gaps relevant to the implementation of these novel therapeutic regimens into clinical practice.
Subscribe to the Society of Interventional Oncology Podcast on your preferred platform to stay up to date with future podcast series and episode releases.

Apple Podcasts: Customer Reviews

No Entry